(Q37868371)

English

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.

scientific article published on May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

Nikolaos Kakouros

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Irene Savelieva

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Antonios Kourliouros

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A John Camm

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

610-625

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Current concepts in the pathogenesis of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Irbesartan in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Losartan and prevention of atrial fibrillation recurrence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers on patients following ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Upstream therapies after pulmonary vein ablation: five negative studies--what's next?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Inflammation as a risk factor for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Lack of effect of statins on maintenance of normal sinus rhythm following electrical cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Statin use and recurrence of atrial fibrillation after successful cardioversion.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Effect of C-reactive protein reduction on paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Dose dependent effect of statins on postoperative atrial fibrillation after cardiac surgery among patients treated with beta blockers.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Impact of lipid-lowering therapy on outcomes in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR023

21 January 2018

Identifiers

10.1093/EUROPACE/EUR023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515595%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37868371&oldid=2138299524"